Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Legend Biotech (LEGN) Total Liabilities (2019 - 2025)

Historic Total Liabilities for Legend Biotech (LEGN) over the last 7 years, with Q3 2025 value amounting to $701.7 million.

  • Legend Biotech's Total Liabilities rose 1322.7% to $701.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $701.7 million, marking a year-over-year increase of 1322.7%. This contributed to the annual value of $629.6 million for FY2024, which is 541.99% up from last year.
  • Legend Biotech's Total Liabilities amounted to $701.7 million in Q3 2025, which was up 1322.7% from $654.4 million recorded in Q2 2025.
  • Legend Biotech's Total Liabilities' 5-year high stood at $535.2 billion during Q2 2021, with a 5-year trough of $353.5 million in Q4 2021.
  • In the last 5 years, Legend Biotech's Total Liabilities had a median value of $602.0 million in 2022 and averaged $56.0 billion.
  • Its Total Liabilities has fluctuated over the past 5 years, first soared by 18435.92% in 2021, then crashed by 9985.28% in 2022.
  • Quarter analysis of 5 years shows Legend Biotech's Total Liabilities stood at $353.5 million in 2021, then soared by 65.95% to $586.7 million in 2022, then grew by 1.8% to $597.2 million in 2023, then increased by 5.42% to $629.6 million in 2024, then rose by 11.45% to $701.7 million in 2025.
  • Its Total Liabilities was $701.7 million in Q3 2025, compared to $654.4 million in Q2 2025 and $597.9 million in Q1 2025.